This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sze, P. C. Articles by Chalmers, T. C. Search for Related Content PubMed PubMed Citation Articles by Sze, P. C. Articles by Chalmers, T. C.

Stroke, Vol 19, 436-442, Copyright © 1988 by American Heart Association

ARTICLES

Antiplatelet agents in the secondary prevention of stroke: meta- analysis of the randomized control trials

PC Sze, D Reitman, MM Pincus, HS Sacks and TC Chalmers
Clinical Trials Unit, Mount Sinai School of Medicine, City University of New York, New York.

Randomized control trials of antiplatelet agents in the prevention of stroke following transient ischemic attacks have had conflicting results. The decision to employ aspirin instead of placebo as the control regimen in trials testing newer antiplatelet agents emphasizes the need for an accurate estimate of the efficacy of older drugs. A meta-analysis of seven randomized control trials comparing aspirin and/or sulfinpyrazone or dipyridamole with placebo was performed. For aspirin compared with placebo, a nonsignificant reduction in stroke of 15% (odds ratio 0.85, 95% confidence interval 0.60-1.19; chi 2 = 0.78, p greater than 0.30) was found. For aspirin combined with sulfinpyrazone or dipyridamole compared with placebo, a 39% reduction in stroke was observed (odds ratio 0.61, 95% confidence interval 0.39- 0.95; chi 2 = 4.22, p less than 0.05); at the same time a 350% increase in gastrointestinal hemorrhage or peptic ulcer was noted (odds ratio 3.5, 95% confidence interval 1.26-9.75; chi 2 = 4.61, p less than 0.05). A trend in reduction of strokes for men was observed (odds ratio 0.58, 95% confidence interval 0.32-1.07; chi 2 = 2.52, p less than 0.15) for any regimen containing aspirin. The significant benefit of aspirin-combination therapy on stroke must be interpreted cautiously because of a number of possible biases. It is still conceivable that aspirin alone may decrease the incidence of stroke by as much as 40%, but a sample of greater than 13,000 patients would be needed to confirm the benefit observed in our analysis.

This article has been cited by other articles:

				J. Leonardi-Bee, P. M.W. Bath, M.-G. Bousser, A. Davalos, H.-C. Diener, B. Guiraud-Chaumeil, J. Sivenius, F. Yatsu, M. E. Dewey, and on behalf of the Dipyridamole in Stroke Collaborat Dipyridamole for Preventing Recurrent Ischemic Stroke and Other Vascular Events: A Meta-Analysis of Individual Patient Data From Randomized Controlled Trials Stroke, January 1, 2005; 36(1): 162 - 168. [Abstract] [Full Text] [PDF]

				G.Y.H. Lip and C.R. Gibbs Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review QJM, July 1, 2002; 95(7): 461 - 468. [Abstract] [Full Text] [PDF]

				L. R. Caplan Treatment of Patients With Stroke Arch Neurol, May 1, 2002; 59(5): 703 - 707. [Full Text] [PDF]

				L R CAPLAN Evidence based medicine: concerns of a clinical neurologist J. Neurol. Neurosurg. Psychiatry, November 1, 2001; 71(5): 569 - 574. [Full Text] [PDF]

				J. M. Holroyd-Leduc, M. K. Kapral, P. C. Austin, and J. V. Tu Sex Differences and Similarities in the Management and Outcome of Stroke Patients Stroke, August 1, 2000; 31(8): 1833 - 1837. [Abstract] [Full Text] [PDF]

				E. S. Johnson, S. F. Lanes, C. E. Wentworth III, M. H. Satterfield, B. L. Abebe, and L. W. Dicker A Metaregression Analysis of the Dose-Response Effect of Aspirin on Stroke Arch Intern Med, June 14, 1999; 159(11): 1248 - 1253. [Abstract] [Full Text] [PDF]

				C. Spaulding, B. Charbonnier, A. Cohen-Solal, Y. Juilliere, E. P. Kromer, K. Benhamda, R. Cador, and S. Weber Acute Hemodynamic Interaction of Aspirin and Ticlopidine With Enalapril : Results of a Double-Blind, Randomized Comparative Trial Circulation, August 25, 1998; 98(8): 757 - 765. [Abstract] [Full Text] [PDF]

				W. S. Moore, H.J.M. Barnett, H. G. Beebe, E. F. Bernstein, B. J. Brener, T. Brott, L. R. Caplan, A. Day, J. Goldstone, R. W. Hobson II, et al. Guidelines for Carotid Endarterectomy : A Multidisciplinary Consensus Statement From the Ad Hoc Committee, American Heart Association Circulation, January 15, 1995; 91(2): 566 - 579. [Abstract] [Full Text]

				W. S. Moore, H.J.M. Barnett, H. G. Beebe, E. F. Bernstein, B. J. Brener, T. Brott, L. R. Caplan, A. Day, J. Goldstone, R. W. Hobson II, et al. Guidelines for Carotid Endarterectomy : A Multidisciplinary Consensus Statement From the Ad Hoc Committee, American Heart Association Stroke, January 1, 1995; 26(1): 188 - 201. [Abstract] [Full Text]

				M. D. McDaniel Meta-analysis: A Tool for Vascular Surgeons ? Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1993; 6(1): 109 - 115. [PDF]